To the Editor:
Changes in serum activities of ␥-glutamyltransferase (GGT), 5Ј-nucleotidase (5NT), and the liver form of alkaline phosphatase (ALP) typically are associated with pathological processes of the liver (1 ) . However, relatively few and sparse data have been published on the biological variability of GGT and 5NT activities in serum, whereas liver ALP is an as yet unstudied analyte from the biological variation point of view (2 ) . We report here a definitive assessment of analytical and biological components of variation of these hepatic enzymes in the same cohort of subjects.
We collected four blood specimens from each of 10 healthy volunteers (5 men and 5 women; age range, 25-50 years) on the same day once a week for 4 weeks. "Healthy" subjects were studied to ensure that any fluctuation in enzyme activities in serum could truly be attributed to biological variation and were not caused by pathological variations in liver structure or function. In accordance with the Helsinki II Declaration, the design and execution of the experiment were explained thoroughly to the subjects, and informed consent was obtained. The inclusion criteria were that the subjects have no evident hepatic disorders by clinical, ecographic, and biochemical evaluation (the activities of the three enzymes being studied, however, were not used), and for women, that they have regular menstrual cycles and not use hormonal contraceptives. In addition, none of the subjects took any medication or consumed substantial (Ͼ10 g of ethanol/day) quantities of alcohol.
Venous blood was obtained between 0800 and 0900 from subjects who had fasted for 12 h and had not smoked or exercised that morning. Samples were collected by the same phlebotomist using vacuum collection tubes with minimal stasis while subjects were in the sitting position. Serum specimens, separated by centrifugation, were stored at Ϫ25°C until analysis. When all of the specimens were available, they were thawed, mixed, centrifuged, and analyzed in a single run in duplicate in random order. GGT and total ALP were determined with the IFCC-recommended methods at 37°C. 5NT activity was determined at 37°C by a kinetic method (Enzyline ® 5ЈNU; BioMerieux). The activity of liver ALP was determined by an electrophoretic procedure with neuraminidase added to the sample 15 min before electrophoresis. Tracings were scanned by densitometry, and liver ALP was calculated by the product of the total ALP activity and the percentage of the stain appearing in the liver ALP region. Enzyme activities were measured with a Dade Behring Mega ® analyzer. The analytical (CV A ), within-subject (CV I ), and between-subject (CV G ) components of variation were calculated by nested ANOVA from replicate analyses (3 ). In particular, CV A was estimated from the duplicate results for each specimen, CV I from the total within-subject variance (referred to as the variance of the mean of duplicate assays) minus one-half the analytical variance, and CV G from the total variance of the data minus the analytical and intraindividual components. The desired analytical imprecision, taken to be Յ0.5 CV I ; the index of individuality (CV I /CV G ), which yields information about the utility of conventional population-based reference intervals; the critical difference [2.77 (CV A 2 ϩ CV I 2 ) 1/2 ], i.e., the minimal significant difference (P Ͻ0.05) between two consecutive measurements of the enzyme in the same patient; and the number of specimens that should be collected to estimate (P Ͻ0.05) the homeostatic set point of an individual within Ϯ 10% [1.96 2 (CV A 2 ϩ CV I 2 )/100] were also estimated (Table 1) (3 ).
As expected, GGT activity was significantly (P Ͻ0.05) higher for men than for women. For GGT and liver ALP, most of the observed variability was biological, whereas 5NT also had high analytical variability. Total ALP was included for the sake of completeness; moreover, because the findings from the present study for this very well-studied enzyme were remarkably similar to the other previously published data (2 ) , this would support the general use of our new data on the three enzymes studied. The desirable analytical imprecision was Յ3.7% for GGT, Յ2.1% for 5NT, and Յ5.0% for liver ALP, respectively. Thus, in this limited assessment, the intrabatch imprecision (CV A ) of GGT and liver ALP met this goal, whereas the 5NT assay did not meet this quality target. 5NT was the marker showing the lowest CV I and the lowest interindividual fluctuation. Calculated average CV I for men 
